公司资料
Ventyx Biosciences, Inc. 股价、新闻与催化剂
已退市
- 股票代码:
- VTYX
- 交易所:
- NASDAQ
- 行业:
- Small Molecule Drugs
- 所在地:
- United States
股价为何变动
目前无法获取 VTYX 的收盘价变动背景。
公司概览
业务概览
Ventyx Biosciences is an immunology company building small-molecule therapies for inflammatory and autoimmune diseases.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Ventyx sits in early-stage biopharmaceuticals.
商业模式特征
The company relies on clinical proof-of-concept, dose selection, and the chance to build a differentiated inflammation pipeline.
生物医药行业定位
Ventyx is a catalyst-driven immunology name whose valuation depends heavily on clinical data quality.
未来催化剂
- Ventyx's catalysts are its inflammation programs, especially the NLRP3 and related assets that still need human proof. The stock remains highly data-sensitive because the platform is still early.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。